These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33288711)

  • 1. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.
    Concilli M; Petruzzelli R; Parisi S; Catalano F; Sirci F; Napolitano F; Renda M; Galietta LJV; Di Bernardo D; Polishchuk RS
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32453-32463. PubMed ID: 33288711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
    Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
    Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
    Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
    Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.
    Catalano F; O'Brien TJ; Mekhova AA; Sepe LV; Elia M; De Cegli R; Gallotta I; Santonicola P; Zampi G; Ilyechova EY; Romanov AA; Samuseva PD; Salzano J; Petruzzelli R; Polishchuk EV; Indrieri A; Kim BE; Brown AEX; Puchkova LV; Di Schiavi E; Polishchuk RS
    Traffic; 2024 Jan; 25(1):e12920. PubMed ID: 37886910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population.
    Allocca S; Ciano M; Ciardulli MC; D'Ambrosio C; Scaloni A; Sarnataro D; Caporaso MG; D'Agostino M; Bonatti S
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
    Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
    Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
    Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
    World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
    Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
    Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structure of Metal Binding Domain 1 of the Copper Transporter ATP7B Reveals Mechanism of a Singular Wilson Disease Mutation.
    Yu CH; Lee W; Nokhrin S; Dmitriev OY
    Sci Rep; 2018 Jan; 8(1):581. PubMed ID: 29330485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
    Forbes JR; Cox DW
    Am J Hum Genet; 1998 Dec; 63(6):1663-74. PubMed ID: 9837819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
    Overeem AW; Klappe K; Parisi S; Klöters-Planchy P; Mataković L; du Teil Espina M; Drouin CA; Weiss KH; van IJzendoorn SCD
    J Hepatol; 2019 Aug; 71(2):344-356. PubMed ID: 30965071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders.
    Fieten H; Gill Y; Martin AJ; Concilli M; Dirksen K; van Steenbeek FG; Spee B; van den Ingh TS; Martens EC; Festa P; Chesi G; van de Sluis B; Houwen RH; Watson AL; Aulchenko YS; Hodgkinson VL; Zhu S; Petris MJ; Polishchuk RS; Leegwater PA; Rothuizen J
    Dis Model Mech; 2016 Jan; 9(1):25-38. PubMed ID: 26747866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
    van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
    Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.
    Kumari N; Kumar A; Thapa BR; Modi M; Pal A; Prasad R
    Hum Mutat; 2018 Dec; 39(12):1926-1941. PubMed ID: 30120852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
    Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
    Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
    de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
    Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.
    Forbes JR; Cox DW
    Hum Mol Genet; 2000 Aug; 9(13):1927-35. PubMed ID: 10942420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human copper transporter ATP7B (Wilson disease protein) forms stable dimers
    Jayakanthan S; Braiterman LT; Hasan NM; Unger VM; Lutsenko S
    J Biol Chem; 2017 Nov; 292(46):18760-18774. PubMed ID: 28842499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.
    Ariöz C; Li Y; Wittung-Stafshede P
    Biometals; 2017 Dec; 30(6):823-840. PubMed ID: 29063292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarized trafficking and copper transport activity of ATP7B: A mutational approach to establish genotype-phenotype correlation in Wilson disease.
    Das S; Mohammed A; Mandal T; Maji S; Verma J; Ruturaj ; Gupta A
    Hum Mutat; 2022 Oct; 43(10):1408-1429. PubMed ID: 35762218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.